Restylane Volyme Lidocaine

Restylane Volyme Lidocaine is a sterile, biodegradable, transparent filler of non-animal cross-linked hyaluronic acid, intended for injection into the supraperiosteal zone or subcutis to augment the volume of the cheeks. Each 1 mL contains cross-linked hyaluronic acid 20 mg/mL, in a phosphate-buffered saline at pH 7, plus 3 mg/mL of lidocaine hydrochloride added to diminish the pain of injection. The filler comes in a prefilled plastic syringe, packed on its own in a blister together with two 27G x 1/2 inch ultra thin wall needles and patient record labels.

• Intended for injection into the supraperiosteal zone or subcutis to augment the volume of the cheeks
• Adds volume to the tissue, restoring the skin contours of the face, through the ability of cross-linked hyaluronic acid to bind water
• Cross-linked hyaluronic acid at 20 mg/mL with lidocaine hydrochloride 3 mg/mL, so no separate anaesthetic is needed at the site
• Sterile, biodegradable and transparent gel of non-animal origin, sterilised by moist heat
• Supplied in a blister with two 27G x 1/2 inch ultra thin wall needles, and a blunt cannula of 27G or wider may be used instead
• Hyaluronic acid based, so the implant can be broken down by enzymatic degradation with hyaluronidase where clinically indicated
• Includes patient record labels for traceability

適応と専門的な使用

主な適応

• Augmentation of the volume of the cheeks, by injection into the supraperiosteal zone or subcutis

専門的な使用

Restylane Volyme Lidocaine is an injectable medical device for administration only by licensed, appropriately trained healthcare practitioners in a controlled clinical setting, and is not for retail sale or self-administration. It is intended for injection into the supraperiosteal zone or subcutis to augment the volume of the cheeks. At each treatment session, a maximum dosage of 1.5 ml per treatment site is recommended. It must not be injected intramuscularly or intravascularly; introduction into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, and rare but serious events, including vision impairment, blindness, cerebral ischaemia and stroke have been reported after intravascular injection of soft tissue fillers in the face.

施術部位

• Cheeks, for volume augmentation

対象となる患者

For adult patients assessed as suitable by the treating practitioner, typically those with volume depletion in the cheeks rather than a single fold to correct. Patient selection, injected volume, plane and technique follow the practitioner's clinical assessment. Because the gel contains lidocaine hydrochloride 3 mg/mL, patients with known hypersensitivity to lidocaine or to amide-type local anaesthetics must not receive it. It must not be used in patients with a history of hypersensitivity to streptococcal proteins, since the gel may contain trace amounts of such material, in patients with severe allergies manifested by a history of anaphylaxis or a history or presence of multiple severe allergies, or in patients presenting with porphyria. It should be used with caution in patients on immunosuppressive therapy and in patients with a tendency to form hypertrophic scars or other healing disorders. Patients with bleeding disorders, or using substances that prolong bleeding, may experience increased bruising.

作用の仕組み： Restylane Volyme Lidocaine ​

Allparaで注文する理由

Allparaは、正規品で検証済みの RESTYLANE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問